Health Empire Corporation PCL (BKK:HEALTH)
Thailand
· Delayed Price · Currency is THB 0.400
-0.020 (-4.76%)
At close: Mar 9, 2026
BKK:HEALTH Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 106.08 | 41.82 | 20.63 | 107.74 | 108.28 | Upgrade
|
| Other Revenue | 2.67 | 3.99 | 4.43 | 10.29 | 16.1 | Upgrade
|
| Revenue | 108.76 | 45.81 | 25.07 | 118.03 | 124.38 | Upgrade
|
| Revenue Growth (YoY) | 137.42% | 82.75% | -78.76% | -5.10% | 14.17% | Upgrade
|
| Cost of Revenue | 57.66 | 22.45 | 9.78 | 60.44 | 50.75 | Upgrade
|
| Gross Profit | 51.1 | 23.36 | 15.28 | 57.59 | 73.62 | Upgrade
|
| Selling, General & Admin | 67.29 | 63.13 | 76.56 | 138.51 | 133.43 | Upgrade
|
| Operating Expenses | 67.29 | 63.13 | 76.56 | 138.51 | 133.43 | Upgrade
|
| Operating Income | -16.19 | -39.77 | -61.28 | -80.92 | -59.8 | Upgrade
|
| Interest Expense | -1.33 | -0.94 | -2.49 | -2.37 | -1.89 | Upgrade
|
| Earnings From Equity Investments | -10.89 | 2.59 | 13.22 | -0.13 | - | Upgrade
|
| EBT Excluding Unusual Items | -28.41 | -38.12 | -50.55 | -83.42 | -61.7 | Upgrade
|
| Impairment of Goodwill | - | -419.63 | -212.81 | -422.29 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -2 | -1.51 | -3.42 | -9 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.01 | 0.04 | 39.46 | 0.65 | Upgrade
|
| Pretax Income | -30.41 | -459.25 | -266.74 | -475.25 | -61.05 | Upgrade
|
| Income Tax Expense | -1.05 | 0.28 | - | 0.58 | 0.37 | Upgrade
|
| Earnings From Continuing Operations | -29.36 | -459.53 | -266.74 | -475.84 | -61.42 | Upgrade
|
| Minority Interest in Earnings | -9.1 | 1.26 | 2.27 | 18.55 | 16.21 | Upgrade
|
| Net Income | -38.46 | -458.27 | -264.47 | -457.29 | -45.21 | Upgrade
|
| Net Income to Common | -38.46 | -458.27 | -264.47 | -457.29 | -45.21 | Upgrade
|
| Shares Outstanding (Basic) | 423 | 392 | 383 | 360 | 213 | Upgrade
|
| Shares Outstanding (Diluted) | 423 | 392 | 383 | 360 | 213 | Upgrade
|
| Shares Change (YoY) | 7.76% | 2.37% | 6.49% | 69.17% | 180.61% | Upgrade
|
| EPS (Basic) | -0.09 | -1.17 | -0.69 | -1.27 | -0.21 | Upgrade
|
| EPS (Diluted) | -0.09 | -1.17 | -0.69 | -1.27 | -0.21 | Upgrade
|
| Free Cash Flow | 2 | -46.97 | -22.97 | -74.37 | -89.83 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.12 | -0.06 | -0.21 | -0.42 | Upgrade
|
| Gross Margin | 46.99% | 50.99% | 60.96% | 48.79% | 59.19% | Upgrade
|
| Operating Margin | -14.88% | -86.82% | -244.49% | -68.56% | -48.08% | Upgrade
|
| Profit Margin | -35.36% | -1000.41% | -1055.14% | -387.43% | -36.35% | Upgrade
|
| Free Cash Flow Margin | 1.84% | -102.53% | -91.65% | -63.01% | -72.23% | Upgrade
|
| EBITDA | -0.35 | -29.9 | -48.97 | -59.52 | -46.03 | Upgrade
|
| EBITDA Margin | -0.32% | -65.26% | -195.37% | -50.43% | -37.00% | Upgrade
|
| D&A For EBITDA | 15.84 | 9.87 | 12.31 | 21.4 | 13.78 | Upgrade
|
| EBIT | -16.19 | -39.77 | -61.28 | -80.92 | -59.8 | Upgrade
|
| EBIT Margin | -14.88% | -86.82% | -244.49% | -68.56% | -48.08% | Upgrade
|
| Revenue as Reported | 108.76 | 45.82 | 25.11 | 159.81 | 125.03 | Upgrade
|
| Advertising Expenses | - | 3.6 | 2.01 | 1.9 | 14.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.